• Texas A&M and Celltex Partnering on a Stem Cell-related Alzheimer’s Treatment
  • Nuplazid Can Treat Psychosis in Alzheimer’s Patients But Benefit Only Seen in Short Term, Study Reports
  • Merck Stops Phase 3 Trial of Verubecestat in Early Alzheimer’s Patients Amid Concerns Over Benefit
  • Harmful Tau Protein Shows Up in One Brain Area, Then Spreads, Study Reports
  • CTD and Kerwin Center Discussing Partnership on Cholesterol-Lowering Therapies for Alzheimer’s
  • Idalopirdine Plus Cholinesterase Inhibitors Doesn’t Help Alzheimer’s Patients, Study Finds
  • Gut Microbiome May Have Central Role in Alzheimer’s and Like Diseases, Study Argues
  • Loss of Nerve Cell Connectors Can Not Explain Cognitive Impairment, Study Concludes
  • Poor Results Prompt Takeda and Zinfandel to End Phase 3 Alzheimer’s Therapy Trial Early
  • Asthma Drug Montelukast Tested as Alzheimer’s Treatment in Proof-of-concept Trial
  • Funding Renewed for Long-term Study of Adult Children of Alzheimer’s Patients
  • Alzheimer’s-Linked Gene Behaves as Virus, Scientists Find in Odd Discovery